TTY Biopharm Company Limited
Research TTY Biopharm Company Limited (4105.TWO) on Bullrun: market cap TWD 20.69B, P/E 12.0, dividend yield 5.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4105.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 20.69B
- P/E12.0
- Dividend yield5.5%
- Financial periodQ2 2026
- RevenueTWD 1.65B
- Net incomeTWD 406.42M
- Free cash flowTWD 174.98M
- Gross margin58.7%
Valuation Snapshot
latest market cap is TWD 20.69B; P/E is 12.0; dividend yield is 5.5%.
Peer valuation comparison
Latest P/E is 11.95x versus a Healthcare sector median of 21.8x (45.2% below).
Latest dividend yield is 5.48% versus a Healthcare sector median of 2.4% (128.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 20.69B | 12.0 | 5.4% | 4.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 4.5 TWD, yield 5.5%.
About TTY Biopharm Company Limited
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, Other Business Unit, and Re-investment Business Unit segments.
ETFs that hold TTY Biopharm Company Limited
US-listed ETFs
TTY Biopharm Company Limited is held by 21 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| iShares Core MSCI Total International Stock ETF (IXUS) | <0.01% | 0.07% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is TTY Biopharm Company Limited's market cap?
TTY Biopharm Company Limited's market capitalization is TWD 20.69B.
What is TTY Biopharm Company Limited's P/E ratio?
TTY Biopharm Company Limited's price-to-earnings (P/E) ratio is 12.0.
Does TTY Biopharm Company Limited pay a dividend?
TTY Biopharm Company Limited has a dividend yield of 5.5%.
What does TTY Biopharm Company Limited do?
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, Other Business Unit, and Re-investment Business Unit segments.